Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies

Authors:

Abstract
No abstract available
Funding Information
  • Biotechnology and Biological Sciences Research Council (BB/K003240/1)
  • National Institutes of Health (P30ESO25128)
  • Wellcome Trust (WT101650MA)
  • Wellcome Trust (WT097835MF)
  • GlaxoSmithKline
  • Academy of Medical Sciences
  • Medical Research Council (MR/P016065/1)
  • Medical Research Council (MR/M008924/1)
  • Medical Research Council (MR/WO14548/1)
  • Medical Research Council (MR/T002239/1)
  • Roche
  • National Institute on Aging (N01-AG-6-2106)
  • National Institute on Aging (N01-AG-6-2101)
  • National Institute on Aging (N01-AG-6-2103)
  • National Institute on Aging (R01-AG028050 2)
  • National Institute of Nursing Research (R01-NR012459)
  • National Institute of Nursing Research (ICS110.1/RF97.71)
  • Ministero della Salute (9072)

This publication has 92 references indexed in Scilit: